KEFEA statement on labelling of pharmaceutical products

The Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA) is surprised by media reports claiming that 40% of pharmaceutical products at state pharmacies are inadequately labelled. In statements, KEFEA President Kyriacos Mikellis said that “as...

Meeting between KEFEA and the Minister of Health

The implementation of a National Health System (NHS) that will guarantee high quality healthcare services as well as other important matters involving the pharmaceutical industry were discussed during the first meeting between Health Minister George Pamborides and the...

KEFEA: New medicine being victimised

Pharmaceutical companies say they are trapped because they cannot delete products from the price list There will be problems in the unimpeded distribution of medicines in the Cyprus market, particularly the availability of new, innovative treatments following the...

KEFEA: In danger of medicinal products being withdrawn

The Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA) is concerned about the Minister of Health’s decision to proceed with a further 8.5% horizontal price cut on private sector medicines. This latest, one-sided measure may create problems...